• Francis L. Black


In 1948, Kenneth Maxcy(78)wrote in a chapter on epidemiology,The simplest of all infectious diseases is measles.” That was before the virus had been isolated or any serological test had become available. Several complicating situations have been found in the intervening years, but they are rare, and Maxcy’s statement is as true now as it was 40 years ago.


Multiple Sclerosis Measle Virus Measle Vaccine Subacute Sclerosing Panencephalitis Measle Case 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aaby, P., Bukh, J., Lisse, I. M., and Smits, A. J., Measles mortality, state of nutrition, and family structure: A community study from Guinea-Bissau,J. Infect. Dis. 147: 693 – 701 (1983).Google Scholar
  2. 2.
    Abu Becr, M.,A Discourse on the Smallpox and Measles(trans. R. Mead), J. Brindley, London, 1748.Google Scholar
  3. 3.
    Adams, J. M., and Imagawa, D. T., Measles antibodies in multiple sclerosis,Proc. Soc. Exp. Biol. Med. 111: 562 – 566 (1962).Google Scholar
  4. 4.
    Albrecht, P., Ennis, F. H., Saltzmen, E. J., and Krugman, S., Persistence of maternal antibody beyond twelve months: Mechanisms of measles vaccine failure,J. Pediatr. 91: 766 – 767 (1977).Google Scholar
  5. 5.
    Anderson, R. M., and May, R. M., Age-related changes in the rate of disease transmission: Implications for the design of vaccination programs,J. Hyg. (Camb.) 94: 365 – 436 (1985).Google Scholar
  6. 6.
    Anderson, R. M., and May, R. M., Vaccination and herd immunity to infectious diseases,Nature 318: 323 – 329 (1985).Google Scholar
  7. 7.
    Babbott, F. L., Galbraith, N. S., McDonald, J. C., Shaw, A., and Zuckerman, A. J., Deaths from measles in England and Wales in 1961,Mon. Bull. Minist. Health Public Health Lab. Serv. 22: 167 – 175 (1963).Google Scholar
  8. 8.
    Bartlett, M. S., Deterministic and stochastic models for recurrent epidemics,Third Berkeley Symp. Math. Stat. Prob. 4: 81 – 109 (1956).MathSciNetGoogle Scholar
  9. 9.
    Bartlett, M. S., The critical community size for measles in the United States,J. R. Stat. Soc. Ser. A 123: 37 – 44 (1960).Google Scholar
  10. 10.
    Bech, V., Studies on the development of complement fixing antibodies in measles patients.J. Immunol. 83: 267 – 275 (1959).Google Scholar
  11. 11.
    Bech, V., Measles epidemics in Greenland,Am. J. Dis. Child. 103: 252 – 253 (1962).Google Scholar
  12. 12.
    Bech, V., The measles epidemic in Greenland,Arch. Ges. Virusforsch. 16: 53 – 56 (1965).Google Scholar
  13. 13.
    Bellanti, J. A., Sanga, R. L., Klutinis, B., Brandt, B., and Artenstein, M. S., Antibody responses in serum and nasal secretion of children immunized with inactivated and attenuated measles virus vaccines,N. Engl. J. Med. 280: 628 – 633 (1969).Google Scholar
  14. 14.
    Benjamin, B., and Ward, S. M., Leukocyte response to measles,Am. J. Dis. Child. 44: 921 – 963 (1932).Google Scholar
  15. 15.
    Berg, R. B., and Rosenthal, M. S., Propagation of measles virus in suspensions of human and monkey leukocytes,Proc. Soc. Exp. Biol. Med. 106: 581 – 585 (1961).Google Scholar
  16. 16.
    Bhatt, P. N., Brandt, C. D., Weiss, R. A., Fox, J. P., and Shaffer, M. F., Viral infections of monkeys in their natural habitat in southern India,Am. J. Trop. Med. Hyg. 15: 561 – 566 (1966).Google Scholar
  17. 17.
    Black, F. L., Growth and stability of measles virus,Virology 7: 184 – 192 (1959).MathSciNetGoogle Scholar
  18. 18.
    Black, F. L., A nationwide survey of United States military recruits, 1962. III. Measles and mumps antibodies,Am. J. Hyg. 80: 304 – 307 (1964).Google Scholar
  19. 19.
    Black, F. L., Measles endemicity in insular populations: Critical community size and its evolutionary implication,Theor. Biol. 11: 207 – 211 (1965).Google Scholar
  20. 20.
    Black, F. L., The role of herd immunity in the control of measles,Yale J. Biol. Med. 55: 351 – 360 (1982).Google Scholar
  21. 21.
    Black, F. L., and Berman, L. L., Measles and mumps, in:Manual of Clinical Laboratory Immunology, 3rd ed. (J. L. Fahey, H. Friedman, and N. R. Rose, eds.), pp. 532 – 535, American Society for Microbiology, Washington, 1985.Google Scholar
  22. 22.
    Black, F. L., Berman, L. L., Borgono, J. M., Capper, R. A., Carvalho, A. A., Collins, C., Glover, O., Huazi, Z., Jacobson, D. L., Lee, Y.-L., Libel, M., Linhares, A. C., Mendizabal-Morris, C. A., Simoes, E., Siqueira-Campos, E., Stevenson, J., and Vecchi, N., Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody,Am. J. Epidemiol. 124: 442 – 452 (1986).Google Scholar
  23. 23.
    Black, F. L., Berman, L. L., Libel, M., Reichelt, C. A., Pinheiro, F. P., Travasso da Rosa, A., Figueira, F., and Siqueira-Campos, E., Inadequate immunity to measles in children vaccinated at an early age: Effect of revaccination,Bull. WHO 62: 315 – 319 (1984).Google Scholar
  24. 24.
    Black, F. L., Hierholzer, W., Woodall, J. P., and Pinheiro, F., Intensified reactions to measles vaccine in unexposed populations of American IndiansJ. Infect. Dis 124: 306 – 317 (1971).Google Scholar
  25. 25.
    Black, F. L., and Rosen, L., Patterns of measles antibodies in residents of Tahiti and their stability in the absence of re-exposure,J. Immunol. 88: 725 – 731 (1962).Google Scholar
  26. 26.
    Black, F. L., and Sheridan, S. R., Studies on attenuated measles–virus vaccine. IV. Administration of vaccine by several routes,N. Engl. J. Med. 263: 166 – 170 (1960).Google Scholar
  27. 27.
    Black, F. L., and Sheridan, S. R., Blood leukocyte response to live measles vaccine,Am. J. Dis. Child. 113: 301 – 304 (1967).Google Scholar
  28. 28.
    Blake, F. C., and Trask, J. D., Studies on measles. II. Symptomatology and pathology in monkeys experimentally infected,J. Exp. Med. 33: 413 – 422 (1921).Google Scholar
  29. 29.
    Bridges, E. L.,Uttermost Part of the Earth, Dutton, New York, 1949.Google Scholar
  30. 30.
    Brown, P., Basright, M., and Gajdusek, D. C., Response to live attenuated measles vaccine in susceptible island populations in Micronesia,Am. J. Epidemiol. 82: 115 – 122 (1965).Google Scholar
  31. 31.
    Celers, J., Problèmes de santé publique poses par la rougeole dans les pay favorisés,Arch. Ges. Virusforsch. 16: 5 – 18 (1965).Google Scholar
  32. 32.
    Centers for Disease Control, Atypical measles—California 1974–1975,Morbid. Mortal. Week. Rep. 25: 245 – 246 (1976).Google Scholar
  33. 33.
    Centers for Disease Control, Measles—United States, 1984,Morbid. Mortal. Week. Rep. 34: 308 (1985).Google Scholar
  34. 34.
    Centers for Disease Control, Recommendations of the immunization practices advisory committee: Measles prevention,Morbid. Mortal. Week. Rep.35: 336, 525 (1986).Google Scholar
  35. 35.
    Chalmers, A. K.,The Health of Glasgow 1818–1925, Bell and Bain, Glasgow, 1930.Google Scholar
  36. 36.
    Christensen, P. E., Henning, S., Bang, H. O., Andersen, V., Jordal, B., and Jensen, O., An epidemic of measles in southern Greenland, 1951: Measles in virgin soil. II. The epidemic proper,Acta Med. Scand. 144: 430 – 449 (1952).Google Scholar
  37. 37.
    Ciongoli, A. K., Platz, P., Dupont, B., Svejgaard, A., Fog, T., and Jerslid, C., Lack of antigen response to myx-oviruses in multiple sclerosis,Lancet 2: 1147 (1973).Google Scholar
  38. Cook, S. D., Dowling, P. D., and Russell, W. C., Multiple sclerosis and canine distemper,Lancet 1: 605 – 606 (1978).Google Scholar
  39. 39.
    Corney, B. G., The behavior of certain epidemic diseases in natives of Polynesia with especial reference to the Fiji Islands,Trans. Epidemiol. Soc. Lond. (N. Ser.) 3: 76 – 95 (1884).Google Scholar
  40. 40.
    Deseda-Tous, J., Cherry, J. D., Spencer, M. J., Williver, R. C., Boyer, K. M., Dudley, J. P., Zahradnik, J. M., Krause, P. J., and Walbergh, E. W., Measles revaccination, persistence and degree of antibody titer by type of immune response,Am. J. Dis. Child. 132: 287 – 290 (1978).Google Scholar
  41. 41.
    Dietz, K., Overall population patterns in the transmission cycle of infectious disease agents, in:Population Biology of Infectious Diseases(R. M. Anderson and R. M. May, eds.), pp. 87 – 102, Springer-Verlag, New York, 1984.Google Scholar
  42. 42.
    Dossetor, J., Whittle, H. C., and Greenwood, B. M., Persistent measles infection in malnourished children,Br. Med. J. 1: 1633 – 1635 (1977).Google Scholar
  43. 43.
    Enders, J. F., and Peebles, T. C., Propagation in tissue cultures of cytopathogenic agents from patients with measles,Proc. Soc. Exp. Biol. Med. 86: 277 – 286 (1954).Google Scholar
  44. 44.
    Fenner, F.,The Impact of Civilization on the Biology of Man(S. V. Boyden, ed.), University of Toronto Press, Toronto, 1970.Google Scholar
  45. 45.
    Fox, J. P., Black, F. L., and Kogon, A., Measles and readiness for reading and learning. V. Evaluative comparison of the studies and overall conclusions,Am. J. Epidemiol. 88: 168 – 175 (1969).Google Scholar
  46. 46.
    Fulginiti, V. A., Eller, J. J., Downie, A. W., and Kempe, C. H., Altered reactivity to measles virus: Atypical measles in children previously immunized with inactivated measles virus vaccines,J.A.M.A. 202: 1075 – 1080 (1967).Google Scholar
  47. 47.
    Fulginiti, V. A., and Helfer, R. E., Atypical measles in adolescent siblings 16 years after killed measles virus vaccine,J.A.M.A. 244: 804 – 806 (1980).Google Scholar
  48. 48.
    Gallagher, M., and Flanagan, T. D., Growth of measles in continuous lymphoid cell lines,Fedl. Proc. 34: 948 (1975).Google Scholar
  49. 49.
    Gibbs, F. A., Gibbs, E. L., Carpenter, P. R., and Spies, H. W., Electroencephalographic abnormality in “uncomplicated” childhood diseases,J.A.M.A. 171: 1030 – 1055 (1959).Google Scholar
  50. 50.
    Gordon, J. E., Janssen, A. A. J., and Ascoli, W., Measles in rural Guatemala,J. Pediatr. 66: 779 – 786 (1965).Google Scholar
  51. 51.
    Greenberg, M., Pellitteri, O., and Eisenstein, D., T., Measles encephalitis. 1. Prophylactic effect of gamma globulin,J. Pediatr. 46: 642 – 647 (1955).Google Scholar
  52. 52.
    Gresser, I., and Katz, S. L., Isolation of measles virus from urine,N. Engl. J. Med. 263: 452 – 454 (1960).Google Scholar
  53. 53.
    Griffiths, D. A., The effect of measles vaccination on the incidence of measles in the community,J. R. Stat. Soc. Ser. A 136: 441 – 449 (1973).Google Scholar
  54. 54.
    Gulick, L. H., On the climate, diseases and materia medica of the Sandwich (Hawaiian) Islands,N.Y. J. Med. 14: 169 – 211 (1855).Google Scholar
  55. 55.
    Haire, M., Fraser, K. B., and Millar, J. H. D., Measles and other virus-specific immunoglobulins in multiple sclerosis,Br. Med. J. 3: 612 – 615 (1973).Google Scholar
  56. 56.
    Halsey, N. A., Boulos, R., Mode, F., Andre, J., Bowman, L., Yaeger, R. G., Tireau, S., Rohde, J., and Boulos, C., Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses,N. Engl. J. Med. 313: 544 – 549 (1985).Google Scholar
  57. 57.
    Halsey, N. A., Modlin, J. F., Jabbour, J. T., Dubey, L., Eddins, D. L., and Ludwig, D. D., Risk factors in subacute sclerosing panencephalitis: A case-control study,Am. J. Epidemiol. 111: 415 – 424 (1980).Google Scholar
  58. 58.
    Hamer, W. H., The Milroy lectures on epidemic disease in England—The evidence of variability and persistency of type,Lancet 1: 733 – 739 (1906).Google Scholar
  59. 59.
    Hankins, R. W.,Serum Antibody Levels against Selected Measles Virus Polypeptides in Multiple Sclerosis Patients and Four Comparison Groups, Dissertation, Yale University, New Haven, 1985.Google Scholar
  60. 60.
    Hedrick, A. W., Monthly estimates of the child population susceptible to measles 1900–1931,Am. J. Hyg. 17: 613 – 636 (1933).Google Scholar
  61. 61.
    Helms, S., and Helms, P., Tuberculin sensitivity during measles,Acta Tuberc. Scand. 35: 166 – 171 (1956).Google Scholar
  62. 62.
    Hinman, A. R., Brandling-Bennett, A. D., and Nieburg, P. I., The opportunity and obligation to eliminate measles from the United States,J.A.M.A. 242:1157–1162(1979).Google Scholar
  63. 63.
    Hirsch, A.,Handbook of Geographical and Historical Pathology, Vol. 1, pp. 154–170, New Sydenham Society, London, 1883.Google Scholar
  64. 64.
    Home, F.,Medical Facts and Experiments, A. Millar, London, 1759.Google Scholar
  65. 65.
    Horta-Barbosa, L., Fuccilo, D. A., Hamilton, R., Traub, R., Ley, A., and Sever, J. L., Some characteristics of SSPE measles virus,Proc. Soc. Exp. Biol. Med. 134: 17 – 21 (1970).Google Scholar
  66. 66.
    Jong, J. G. de, and Winkler, K. O., Survival of measles virus in air,Nature 201: 1054 – 1055 (1964).Google Scholar
  67. 67.
    Katz, S. L., Measles—forgotten but not gone,N. Engl. J. Med. 313: 577 – 578 (1985).Google Scholar
  68. 68.
    Katz, S. L., Kempe, C. H., Black, F. L., Lepow, M. L., Krugman, S., Haggerty, R. J., and Enders, J. F., Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccination,N. Engl. J. Med. 273: 180 – 184 (1960).Google Scholar
  69. 69.
    Koprowski, H., The role of hyperergy in measles encephalitis,Am. J. Dis. Child. 103: 273 – 278 (1962).Google Scholar
  70. 70.
    Koster, F. T., Curlin, G. C., Aziz, K. M. A., and Haque, A., Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh,Bull. WHO 59: 901 – 908 (1981).Google Scholar
  71. 71.
    Krause, P. J., Cherry, J. D., Carney, J. M., Naiditch, H. J., and O’Connor, K., Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories,Am. J. Dis. Child. 134: 561 – 571 (1980).Google Scholar
  72. 72.
    Krause, P. J., Cherry, J. D., Naiditch, M. J., Desadá-Tous, J., and Walbergh, E. W., Revaccination of previous recipients of killed measles vaccine: Clinical and immunological studies,J. Pediatr. 93: 565 – 571 (1978).Google Scholar
  73. 73.
    Kress, S., Schluederberg, A. E., Hornick, R. B., Morse, L. J., Cole, J. L., Slater, E. A., andMcCrumb, F. R., Studies with live attenuated measles-virus vaccine. II. Clinical and immunological response of children in an open community,Am. J. Dis. Child. 101: 701 – 707 (1961).Google Scholar
  74. 74.
    Krugman, S., Giles, J. P., Jacobs, A. M., and Friedman, H., Studies with a further attenuated live measles-virus vaccine,Pediatrics 66: 471 – 488 (1965).Google Scholar
  75. 75.
    Landlaekni, Heilbrigdisskyslur (Public Health in Iceland), Rikisprentsmidjan Gutenberg, Reykjavik, 1941–1950.Google Scholar
  76. 76.
    Lennon, J. L., and Black, F. L., Maternally derived measles immunity in the era of vaccine-protected mothers,J. Pediatr. 108: 671 – 676 (1986).Google Scholar
  77. 77.
    Mata, L.,The Children of Santa Maria Cauque, M.I.T. Press, Cambridge, MA, 1978.Google Scholar
  78. 78.
    Maxcy, K. F., Principles and methods of epidemiology, in:Viral and Rickettsial Infections of Man(T. M. Rivers, ed.), pp. 128 – 146, Lippincott, Philadelphia, 1948.Google Scholar
  79. 79.
    Mazuk, J. van, Pinheiro, F. P., and Black, F. L., Measles and measles vaccine in isolated Amerindian tribes. The 1971 Trio (Tiriyo) epidemic,Trop. Geog. Med. 34: 3 – 6 (1982).Google Scholar
  80. 80.
    McCormick, J. B., Halsey, N. A., and Rosenberg, R., Measles vaccine efficacy determined from secondary attack rate during a severe epidemic,J. Pediatr. 90: 13 – 16 (1977).Google Scholar
  81. 81.
    McCrumb, F. R., Kress, S., Saunders, E., Snyder, M. J., and Schluederberg, A. E., Studies with live attenuated measles vaccine. I. Clinical and immunological responses in institutionalized children,Am. J. Dis. Child. 101: 689 – 700 (1961).Google Scholar
  82. 82.
    McNeill, W. H., Plagues and Peoples: A Natural History of Infectious Diseases, Doubleday, New York, 1976.Google Scholar
  83. 83.
    Measles Sub-committee: Committee on Development of Vaccines and Immunization Procedures, Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine,Lancet 2: 571 – 575 (1977).Google Scholar
  84. 84.
    Meulen, V. ter, Müller, D., Käckell, Y., Katz, M., and Mayermann, R., Isolation of infectious measles virus in measles encephalitis,Lancet 2: 1172 – 1175 (1972).Google Scholar
  85. 85.
    Meyer, H. M., Mass vaccination against measles in Upper Volta,Arch. Ges. Virusforsch. 16: 243 – 245 (1965).Google Scholar
  86. 86.
    Modlin, J. F., Jabbour, J. T., Witte, J. J., and Halsey, N. A., Epidemiologic studies of measles, measles vaccine and subacute sclerosing panencephalitis,J. Pediatr. 59: 505 – 509 (1977).Google Scholar
  87. 87.
    Morley, D., The severe measles of West Africa,Proc. R. Soc. Med. 57: 846 – 849 (1969).Google Scholar
  88. 88.
    Myers, J. M., Assimilation to the ecological and social systems of a community,Am. Sociol. Rev. 15: 367 – 370 (1950).Google Scholar
  89. 89.
    Nathanson, N., and Miller, A., Epidemiology of multiple sclerosis: Critique of the evidence for a viral etiology,Am. J. Epidemiol. 107: 451 – 461 (1978).Google Scholar
  90. 90.
    Nathanson, N., Yorke, J. A., Pianigiani, G., and Martin, J., Requirements for perpetuation and eradication of viruses in populations, in:Persistent Viruses(J. D. Stevens, G. J. Todaro, and C. F. Foy, eds.), pp. 75 – 100, Academic Press, New York, 1978.Google Scholar
  91. 91.
    Neel, J. V., Centerwall, W. R., Chagnon, N. A., and Casey, H. L., Notes on the effects of measles in virgin–soil population of South American Indians,Am. J. Epidemiol. 91: 418 – 429 (1970).Google Scholar
  92. 92.
    Norrby, E., Measles, in:Manual of Clinical Microbiology, 3rd ed. (E. H. Lennette, A. Ballows, W. J. Hauser, and J. P. Truant, eds.), pp. 852 – 856, American Society for Microbiology, Washington, 1980.Google Scholar
  93. 93.
    Norrby, E., Enders-Ruckle, G., and ter Meulen, V., Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus,J. Infect. Dis. 132: 262 – 269 (1975).Google Scholar
  94. 94.
    Nutels, N., Medical problems of newly contacted Indian groups,Pan. Am. Health Organ. Sci. Publ. 165: 68 – 76 (1968).Google Scholar
  95. 95.
    Pampiglione, G., Prodromal phase of measles: Some neurophysiological studies,Br. Med. J. 2: 1296 – 1300 (1964).Google Scholar
  96. 96.
    Pan American Health Organization and the Ministries of Health of Brazil, Chile and Ecuador, Seroconversion rates and measles antibody titer induced by measles vaccine in Latin American children 6–12 months of age,Bull. Pan. Am. Health Org. 16: 272 – 285 (1983).Google Scholar
  97. 97.
    Panum, P. L.,Observations Made during the Epidemic of Measles on the Faroe Islands in the Year 1846, American Publishing Association, New York, 1940.Google Scholar
  98. 98.
    Papp, K., Experiences prouvant que a voie d’infection de la rougeole est la contamination de la muguese conjontivale,Rev. Immunol. 20: 27 – 36 (1956).Google Scholar
  99. 99.
    Paty, D. W., Furesz, J., Boucher, W., Rand, C. G., and Stiller, C. R., Measles antibodies as related to HLA types in multiple sclerosis,Neurology (Minneap.) 20: 651 – 655 (1976).Google Scholar
  100. 100.
    Payne, F. E., and Baublis, J. V., Decreased reactivity of SSPE strains of measles virus with antibody,J. Infect. Dis. 127: 505 – 511 (1973).Google Scholar
  101. 101.
    Peart, A. F. W., and Nagler, F. P., Measles in the Canadian Arctic 1952,Can. J. Public Health 45: 146 – 157 (1954).Google Scholar
  102. 102.
    Rawls, W. E., Rawls, M. L., and Chernesky, M. H., Analysis of a measles epidemic: Possible role of vaccine failures,Can. Med. Assoc. J. 113: 941 – 944 (1975).Google Scholar
  103. 103.
    Richardson, C. D., Berkovitch, A., Rosenblatt, S., and Bellini, W. J., Use of antibodies directed against synthetic peptides for identifying cDNA clones, establishing reading frames, and deducing gene order of measles virus,J. Virol. 53: 186 – 193 (1985).Google Scholar
  104. 104.
    Ristori, C., Boccardo, H., Borgono, J. M., and Armijo, R., Medical importance of measles in Chile,Am. J. Dis. Child. 103: 236 – 241 (1962).Google Scholar
  105. 105.
    Ruckdeschel, J. C., Graziano, K. D., and Mardiney,M. R., Jr., Additional evidence that the cell-associated immune system is the primary host defense against measles,Cell. Immunol. 17: 11 – 18 (1975).Google Scholar
  106. 106.
    Sabin, A. B., Arechiga, A. F., Fernandez de Castro, J., Albrecht, P., Sever, J. L., and Shekarchi, I., Successful immunization of infants with and without maternal antibody by aerosolized vaccine. II. Vaccine comparisons and evidence for multiple antibody response,J.A.M.A. 252: 2363 – 2371 (1984).Google Scholar
  107. 107.
    Salmi, A. A., Norrby, E., and Panelius, M., Identification of different measles virus-specific antibodies in the serum and cerebro-spinal fluid from patients with sub-acute sclerosing panencephalitis and multiple sclerosis,Infect. Immun. 6: 248 – 254 (1972).Google Scholar
  108. 108.
    Sartwell, P. E., The distribution of incubation periods of infectious disease,Am. J. Hyg. 51: 310 – 318 (1950).Google Scholar
  109. 109.
    Schluederberg, A. E., Immune globulins in human viral infections,Nature 205: 1232 – 1233 (1965).Google Scholar
  110. 110.
    Schultz, F.,Die Epidemiologic der Masern, Gustav Fisher, Jena, 1925.Google Scholar
  111. 111.
    Scrimshaw, N. S., Solomon, J. B., Bruch, H. A., and Gordon, J. E., Studies of diarrheal disease in Central America. VIII. Measles, diarrhea and nutritional deficiency in Guatemala, Am.J. Trop. Med. 15: 625 – 631 (1966).Google Scholar
  112. 112.
    Suringa, D. W. R., Bank, L. J., and Ackerman, A. B., Role of measles in skin lesions and Koplik spots,N. Engl. J. Med. 283: 1139 – 1142 (1970).Google Scholar
  113. 113.
    Sydenham, T.,The Works of Thomas Sydenham, Vol. 2, pp. 250–251, Sydenham Society, London, 1922.Google Scholar
  114. 114.
    Tooth, J. S. H., and Lewis, I. C., Measles epidemic in a primitive isolated community,Med. J. Aust. 1: 182 – 186 (1963).Google Scholar
  115. 115.
    Utermohlen, V., and Zabriskie, J. B., A suppression of cellular immunity in patients with multiple sclerosis,J. Exp. Med. 138: 1591 – 1596 (1973).Google Scholar
  116. 116.
    Valdimarsson, H., Agnarsdottir, G., and Lachmann, P. J., Measles virus receptor on human T lymphocytes,Nature 225: 554 – 556 (1975).Google Scholar
  117. 117.
    Whittle, H. C., Rowland, M. G. M., Mann, G. F., Lamb, W. H., and Lewis, R. A., Immunization of 4–6 month old Gambian infants with Edmonston–Zagreb measles vaccine,Lancet 2: 834 – 837 (1984).Google Scholar
  118. 118.
    Wilkins, J., and Wehrle, P. F., Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunization,J. Pediatr. 94: 865 – 869 (1979).Google Scholar
  119. 119.
    World Health Organization, Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children,Bull. WHO 55: 21 – 31 (1977).Google Scholar
  120. 120.
    World Health Organization and UNICEF, Statement of vitamin A for measles,EPI Newsletter 9: 6 – 8 (1987).Google Scholar
  121. 121.
    Yeager, A. S., Davis, J. H., Ross, L. A., and Harvey, B. S., Measles immunization successes and failures,J.AM.A. 237: 347 – 351 (1977).Google Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Francis L. Black
    • 1
  1. 1.Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA

Personalised recommendations